BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 1403138)

  • 1. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.
    Shulkin BL; Shapiro B; Hutchinson RJ
    J Nucl Med; 1992 Oct; 33(10):1735-40. PubMed ID: 1403138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
    Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
    J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?].
    Sautter-Bihl ML; Bihl H; Heinze HG
    Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy.
    Turba E; Fagioli G; Mancini AF; Rosito P; Galli A; Alvisi P
    J Nucl Biol Med (1991); 1993 Sep; 37(3):107-14. PubMed ID: 8218456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma.
    Parisi MT; Greene MK; Dykes TM; Moraldo TV; Sandler ED; Hattner RS
    Invest Radiol; 1992 Oct; 27(10):768-73. PubMed ID: 1399431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine-131 MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma.
    Shulkin BL; Shen SW; Sisson JC; Shapiro B
    J Nucl Med; 1987 Mar; 28(3):315-8. PubMed ID: 3102702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the utility of
    Gauguet JM; Pace-Emerson T; Grant FD; Shusterman S; DuBois SG; Frazier AL; Voss SD
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
    Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does I-131-MIBG underestimate skeletal disease burden in neuroblastoma?
    Barai S; Bandopadhayaya GP; Malhotra A; Agarwal S; Kumar R; Dhanapathi H
    J Postgrad Med; 2004; 50(4):257-60; discussion 260-1. PubMed ID: 15623965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases].
    Lumbroso J; Guermazi F; Hartmann O; Coornaert S; Rabarison Y; Lemerle J; Parmentier C
    Bull Cancer; 1988; 75(1):97-106. PubMed ID: 3359060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroblastoma: imaging evaluation by sequential Tc-99m MDP, I-131 MIBG, and Ga-67 citrate studies.
    Garty I; Friedman A; Sandler MP; Kedar A
    Clin Nucl Med; 1989 Jul; 14(7):515-22. PubMed ID: 2766633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [131I-MIBG scintigraphy for the detection of metastatic lesions from malignant pheochromocytoma--comparison of 131I-MIBG scintigraphy with 99mTc-MDP bone scintigraphy in detecting bone metastases].
    Ozawa N; Imaeda T; Seki M; Koike S
    Kaku Igaku; 1988 Jan; 25(1):97-103. PubMed ID: 3373813
    [No Abstract]   [Full Text] [Related]  

  • 13. 131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.
    El-Maghraby T
    Gulf J Oncolog; 2007 Jul; (2):33-41. PubMed ID: 20084722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroblastoma: dose-related sensitivity of MIBG scanning in detection.
    Parisi MT; Matthay KK; Huberty JP; Hattner RS
    Radiology; 1992 Aug; 184(2):463-7. PubMed ID: 1620849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse bone marrow uptake [123I]MIBG in neuroblastoma: an "MIBG super scan" case report.
    Giammarile F; Olier AL; Lumbroso J
    Q J Nucl Med; 1995 Jun; 39(2):119-21. PubMed ID: 8574805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 131I-meta-iodobenzylguanidine scintigraphy in patients with neuroblastoma.
    Hibi S; Todo S; Imashuku S; Miyazaki T
    Pediatr Radiol; 1987; 17(4):308-13. PubMed ID: 3601463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology.
    Hadj-Djilani NL; Lebtahi NE; Delaloye AB; Laurini R; Beck D
    Eur J Nucl Med; 1995 Apr; 22(4):322-9. PubMed ID: 7607262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases.
    Geatti O; Shapiro B; Sisson JC; Hutchinson RJ; Mallette S; Eyre P; Beierwaltes WH
    J Nucl Med; 1985 Jul; 26(7):736-42. PubMed ID: 4009283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of 131I-meta-iodobenzylguanidine in pediatric oncology].
    Treuner J
    Nuklearmedizin; 1985 Feb; 24(1):26-8. PubMed ID: 4000978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
    Clarke SE; Lazarus CR; Wraight P; Sampson C; Maisey MN
    J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.